Computer software as a service (SAAS) featuring computer software for accessing, hosting, managing, developing, analyzing and maintaining scalable computer hardware, computer software, computer applications, websites, and databases for others accessible via private and global computer networks in the field of financial services; Platform as a service (PAAS) featuring computer software platforms for accessing, hosting, managing, developing, analyzing and maintaining scalable computer hardware, computer software, computer applications, websites, and databases for others accessible via private and global computer networks in the field of financial services; Infrastructure as a service (IAAS) featuring computer software platforms for accessing, hosting, managing, developing, analyzing and maintaining scalable cloud computing infrastructure services accessible via private and global computer networks in the field of financial services; cloud computing featuring software operable via servers, Internet protocol networks, data storage and hosting infrastructure that makes resources available to customers through a set of interfaces in the field of financial services; software as a service (SAAS) services featuring a scalable software for use in high speed, low latency transacting; application service provider (ASP) and software as a service (SAAS) services featuring software matching engines for routing, allocating and processing trades on a financial exchange; software as a service (SAAS) featuring software for matching, routing, allocating and processing bids and offers on a financial exchange; cloud computing services, namely, cloud hosting in the nature of a scalable computer software for providing access to an electronic financial exchange; providing temporary use of on-line non-downloadable software for accessing financial information and transacting and trading of securities and other financial instruments and general high performance computing.

Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type